Leuko

medical devices

About

Leuko is a medical technology company based in Kendall Square, Cambridge, Massachusetts, and is an MIT spinout focused on hematology innovation. The company is developing PointCheck™, the first non-invasive device for monitoring white blood cell levels. This technology aims to enhance the quality of life for immunosuppressed patients, particularly those undergoing chemotherapy, by allowing convenient at-home monitoring without the need for blood draws. PointCheck™ is a portable device that uses light to image blood cells in capillaries near the fingernail. AI algorithms analyze these images to determine white blood cell levels. The device is currently investigational and not yet available for sale. Leuko's mission includes reducing hospital admissions related to low white blood cell counts and addressing the healthcare costs associated with chemotherapy. The company is committed to fostering a collaborative environment and aims to expand its impact globally through strategic partnerships and clinical studies.

Technologies

GmailGoogle AppsCloudflare DNSTypekitGoogle Tag ManagerGoogle AnalyticsMobile FriendlyIoTRemote

Keywords

medical devicesdiagnosticsmedical technologyclinical imagingbioengineeringmedical equipment manufacturingoptical imagingmedical diagnosticsimmunosuppressed patient careneutropenia detectionblood flow imagingregulatory complianceneutropenia screeningmachine learning in healthcarenailfold capillary imaginghealthcare equipment & suppliesai biomedical imaginghealthtech innovationmedical equipment and supplies manufacturingreverse lens microscopysuperficial capillary blood flowmedical device innovationbiomedical signal processinghome diagnosticsmedical aiclinical validationmedical device developmentai-based blood analysisbiotechnologyportable medical device

Location

8 St Marys St, Boston, Massachusetts, United States, 02215

Related Companies

Companies in the same industry